AI-generated price forecast for Gilead Sciences (GILD) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of October 2026: K3vl4r's calibrated AI forecast currently reads GILD as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 147.10. See our public, auditable track record →
Last price
147.10
AI outlook
1/1 bullish
Timeframes up
1 / 1
| Horizon | Direction | Calibrated move (end of horizon) |
|---|---|---|
| 1-hour | — | — |
| 4-hour | — | — |
| Daily~4 weeks out | ▲ Up | +13.88% |
| Weekly | Not enough track record yet | — |
Calibrated: each horizon's forecast is weighted by how often the model has called GILD's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.
Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.
| Member | Action | Date | Amount |
|---|---|---|---|
| Jared Moskowitz (dependent) | ▲ Buy | 2026-05-06 | $1001–15000 |
| Alan Armstrong | ▲ Buy | 2026-03-27 | $1001–15000 |
| Josh Gottheimer (joint) | ▲ Buy | 2026-01-27 | $1001–15000 |
Track what Congress is trading across the whole market in the app — get started free.
From the market-news feed the forecasts are read against.
🔒
See the full GILD forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's calibrated AI forecast currently reads GILD as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects GILD toward $167.86 over the next ~4 weeks, a +13.9% move from $147.39. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Biotech & Pharma forecasts — browse the full sector.
Or see the full GILD price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.